04 September 2010
Keywords: European Commission, Anti-microbial resistance, Antibiotics
Article | 19 November 2009
The European Commission has presented a staff working paper that aims to be the basis of discussion on the ways to better tackle the growing health problem of anti-microbial resistance (AMR). The question of antibacterial resistance has been at the forefront on both sides of the Atlantic, and at the World Health Organization, mostly recently culminating in President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union Presidency, establishing a transatlantic task force to address this urgent and growing problem that threatens patient safety and public health worldwide. (The Pharma Letter November 9).
Each year about 25,000 patients die in the European Union from infections caused by micro-organisms that have developed resistance to antimicrobial medicines. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscriptions are £60 per month, pay as you go.
Find out more details.